title: [Prospective analysis of conservative treatment of acute coronary syndrome].
abstract: The in-hospital and intermediate outcomes in 341 patients with acute coronary syndrome treated with conservative (non-invasive) interventions were analysed. The coronary reperfusion was achieved in 59% patients with acute myocardial infarction (MI) treated with thrombolysis, but in 27% patients with MI treated only heparin and aspirin. In-hospital survival was 91% in 93 patients with MI treated with thrombolysis and 82% in 71 patients with MI without thrombolysis. On 6 month survival was 86% in patients with MI treated with thrombolysis, 70% in patients with MI without thrombolysis, 79% in patients with non-Q-wave MI and 88% in patients with unstable angina.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Niiazova-Karben
authors.forename: B A
authors.initials: BA
authors.lastname: Sidorenko
authors.forename: T A
authors.initials: TA
authors.lastname: Batyraliev
authors.forename: D V
authors.initials: DV
authors.lastname: Preobrazhenskiĭ
authors.forename: I V
authors.initials: IV
authors.lastname: Pershukov
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Pia
authors.forename: B S
authors.initials: BS
authors.lastname: Daniiarov
mesh_terms: D000208:Acute Disease; D000328:Adult; D000789:Angina, Unstable / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D003627:Data Interpretation, Statistical; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011446:Prospective Studies; D016019:Survival Analysis; D013577:Syndrome; D015912:Thrombolytic Therapy; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D001241:Aspirin